The quadrivalent meningococcal conjugate vaccine (Menactra, MCV4, or Menveo) protects against 4 serotypes (A, C, W and Y) of meningococcal disease and is the one required for all full time college students 16 through 21 years of age. It’s routinely recommended at age 11-12 years with a booster at age 16.  Students receiving their first dose on or after their 16th birthday do not need a booster.
Individuals in certain high risk groups may need to receive the Meningococcal serogroup B vaccine (Bexsero and Trumenba) to protect against serogroup B meningococcal disease based on their doctor’s recommendations.  It is not required for college students at this time.